Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DiaSys sees growth in Middle East IDD (infectious disease diagnostics) market:

This article was originally published in Clinica

Executive Summary

There is an expanding market for infectious disease diagnostics in the Middle East and Pakistan, driven by World Health Organization initiatives to eradicate major infectious diseases, increasing international travel and immigration, and growing interest in standardisation and accreditation among healthcare authorities. So says DiaSys, the Waterbury, Connecticut test maker that has just signed distribution deals in the region. Distributors in Kuwait, Oman, Bahrain and Pakistan will exclusively promote, sell and service diagnostic products including tools for analysing parasites in human body fluids, urine sediment analysis products and a range of rapid tests for infectious diseases.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT058536

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel